Email this article 
Long-term neurocognitive effects of chimeric antigen receptor T-cell therapy: Integrating assessments into nursing practice
Abstract
           Chimeric antigen receptor T-cell (CAR-T) therapy is a newly evolving therapy with well-known acute neurotoxic effects. While the long-term neurotoxic effects of this therapy are under researched, they exist in subsets of the post-treatment population. Nurses can focus on assessments before and after CAR-T therapy to determine the degree to which these neurotoxic effects progress. These assessments include subjective and objective tools, as well as an understanding of risk factors associated with a higher degree of adverse cognitive events. By utilizing current research, hematological nurses can advocate for this unmet need to be monitored and intervened upon to improve patient outcomes.
Keywords: chimeric antigen receptor therapy, nursing assessments, neurotoxic effects
Full Text:
PDFReferences
Anglin, P., Elsawy, M., & Shafey, M. (2021). CARE guidance: Integration of CAR T in DLBCL. Community Academic Research Education. https://careeducation.ca/wp-content/uploads/2021/08/CARE_Guidance_Integration_of_CAR-T_in_DLBCL-.pdf
Basch, E., Barbera, L., Kerrigan, C. & Velikova, C. (2018). Implementation of patient-reported outcomes in routine medical care. American Society of Clinical Oncology Educational Book, (38), 122-134. https://doi.org/10.1200/EDBK_200383
Chakraborty, R., Sidana, S., Shah, G.L., Scordo, M., Hamilton, B.K. & Majhail, N.S. (2019). Patient reported outcomes with chimeric antigen receptor t cell therapy: challenges and opportunities. Biology of Blood and Bone Marrow Transplantation, 25(5), e155-e162. https://doi.org/10.1016/j.bbmt.2018.11.025
Clout, R., Murray, J., Farrell, M., Hutt, D. & Kenyon, M. (2023). Cell therapy nursing implications and care. IN M. Kenyon & A. Babic (Eds.), The European blood and marrow transplantation textbook for nurses (pp. 101-122). Springer.
Cordeiro, A., Bezerra, E.D., Hirayama, A.V., Hill, J.A., Wu, Q.V., Voutsinas, J., Sorror, M.L., Turtle, C.J., Maloney, D.G. & Bar, M. (2020). Late events after treatment with CD19-targets chimeric antigen receptor modified T cells. Biology Blood and Marrow Transplantation, 26(1), 26-33. https://doi.org/10.1016/j.bbmt.2019.08.003
Grigor, E., Fergusson, D., Kekre, N., Montroy, J., Atkins, H ., Seftel, M., Daugaard, M., Presseau, J., Thavorn, K., Hutton, B., Holt, R. & Lalu, M. (2019). Risks and benefits of chimeric antigen receptor t-cell (CAR-T) therapy in cancer: A systematic review and meta analysis. Transfusion Medicine Reviews, 22(2), 98-110. https://doi.org/10.1016/j.tmrv.2019.01.005
Harrison, R., Sharafeldin, N., Rexer, J.L., Streck, B., Petersen, M., Henneghan, A. & Kesler, S. (2021). Neurocognitive impairment after hematopoietic stem cell transplant for hematologic malignancies: phenotype and mechanisms. The Oncologist, 26(11), e2021-e2033. https://doi.org/10.1002/onco.13867
He, J., Li, J., Feng, L.N., Feng, L.X., Qiang, W., Wang, W. & Dong, L. (2024). Oncology nurse competency in chimeric antigen receptor T-cell therapy: a qualitative study. Nurse Education Today, 132. https://doi.org/10.1016/j.nedt.2023.106040
Hoogland, A., Rodriquez, Y., James, B.W., Khimani, F., Nishihori, T., Locke, F.L., Jayani, R.V., Collier, A., Irizarry-Arroyo, N., Jain, M.D., Booth-Jones, M., Hyland, K.A., Barata, A., Bachmeier, C., Chavex, J., Krivenko, G.S., Lazaryan, A., Liu, H.D., Pnilla-Ibarz, J. & Jim, H.S.L. (2021). Acute patient-reported outcomes in B-cell malignancies treated with axicabtagene ciloleucel. Cancer Medicine, 10(6),1936-1943. https://doi.org/10.1002/cam4.3664
Kamal, M., Joseph, J., Greenbaum, U., Jicklen, R., Kebriaei, P., Sour, S.A. & Wang, X.S. (2021). Patient-reported outcomes for cancer patients with hematological malignancies undergoing chimeric antigen receptor therapy: a systematic review. Transplantation and Cellular Therapy, 27(5), 390.e1-390.e7. https://doi.org/10.1016/j.jtct.2021.01.003
Kim, H.J., Jun, S.O., Kim, H. & Abraham, I. (2020). Systematic review of longitudinal studies on chemotherapy-associated subjective cognitive impairment in cancer patients. Psycho-Oncology, 29(4), 617-631. https://doi.org/10.1002/pon.5339
Kirtaine, K. & Lee, S.J. (2017). Racial and ethnic disparities in hematologic malignancies. Blood, 130(15), 1699-1705. https://doi.org/10.1182/blood-2017-04-778225
Koll, T.T., Sheese, A., Semin J., Ernst, W., High, R., Wildes, T., Fisher, A. & Murman, D. (2020). Screening for cognitive impairment in older adults with hematological malignancies using the Montreal Cognitive Assessment and neuropsychological testing Journal of Geriatric Oncology, 11(2), 297-303. https://doi.org/10.1016/j.jgo.2019.11.007
Kotb, M.G., Soliman, A., Ibrahim, R., Said, R.M.M. & Wahid El Din, M. (2019). Chemotherapy-induced cognitive impairment in hematological malignancies. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 55(56). https://doi.org/10.1186/s41983-019-0104-9
Libert, Y., Borghgraef, C., Beguin, Y., Delvaux, N., Devos, M., Doyen, C., Dubruille, S., Etienne, A., Lienard, A., Merckaert, I., Reynaert, C., Slachmuylder, J., Straetmans, N., van Den Neste, E., Bron, D. & Razavi. D. (2016). Cognitive compensatory processes of older, clinically fit patients with hematologic malignancies undergoing chemotherapy: a longitudinal cohort study. Psycho-Oncology, 26(12), 2086-2093. https://doi.org/10.1002/pon.4424
Nakamura, Z.M., Deal, A.M., Rosenstein, D., Quillen, L., Chien, S., Wood, W., Shea, T. & Park, E. (2020). Cognitive function in patients prior to undergoing allogeneic hematopoietic stem cell transplantation. Supportive Care in Cancer, 29(4), 2007-2014. https://doi.org/10.1007/s00520-020-05697-2
National Institute of Neurological Disorders and Stroke. (2023, January 20). Neurotoxicity. National Institute of Neurological Disorders and Stroke. https://www.ninds.nih.gov/health-information/disorders/neurotoxicity
National Library of Medicine. (2023, October 1). Clinical Trials. https://clinicaltrials.gov/search?cond=CAR%20T
Puts, M., Strohschien, F., Oldenmenger, W., Haase, K., Newton, L, Fitch, M., Sattar, S., Stolz-Baskett, P., Jin, R., Loucks. A., Nightingale, G. & Kenis, C. (2021). Position statement on oncology and cancer nursing care for older adults with cancer and their caregivers of the International Society of Geriatric Oncology Nursing and Allied Health Interest Group, the Canadian Association of Nurses in Oncology & Aging Special Interest Group, and the European Oncology Nursing Society, Journal of Geriatric Oncology, 12(4), 1000-1004. https://doi.org/10.1016/j.jgo.2021.03.010
Ruark, J., Mullane, E., Cleary, N., Cordeiro, A., Bezerra, E.D., Wu, V., Voutsinas, J., Shaw, B.E., Flynn, K.E., Lee, S.J., Turtle, C.J., Maloney, D.G., Fann, J.R. & Bar, M. (2020). Patient-reported neuropsychiatric outcomes of long term survivors after chimeric antigen receptor therapy. Biology of Blood and Marrow Transplantation, 26(1), 34-43. https://doi.org/10.1016/j.bbmt.2019.09.037
Schagen, S.B., Tsvetkov, A.S., Compter, A. & Wefel, J.S. (2022). Cognitive adverse effects of chemotherapy and immunotherapy: are interventions within reach? Nature Reviews Neurology, 18, 173-185. https://doi.org/10.1038/s41582-021-00617-2
Scott, B.J., Murray, T., Deutsch, G.K., Lahijani, S., Frank, M.J., & Monje, M. (2022). Long-term cognitive and neuropsychiatric outcomes in adults who have received chimeric antigen receptor t-cell (CAR-T) therapy for aggressive lymphoma at Stanford – a pilot feasibility study. Blood, 140(1), 5201-5202. https://doi.org/10.1182/blood-2022-168229
Sidana, S., Dueck, A.C., Thanarajasingam, G., Griffin, J.M., Thompson, C., Durani, R., Burtis, M., Warsame, R., Paludo, J., Gertz, M.A., Dispenzieri, A., Ansell, S.M., Rajkumar, V., Yost, K., Bennani, N., Lin, Y. & Kumar, S. (2022). Longitudinal patient reported outcomes with CAR-T cell transplant versus autologous and allogeneic stem cell transplant. Transplantation and Cellular Therapy, 28(8), 473-482.
https://doi.org/10.1016/j.jtct.2022.05.004
Steinbach, M., Zitella, L.S., Florendo, E., Lee, E., Riccobono, C., DiFlippo, H. & Aronson, E. (2023). Nursing care throughout the chimeric antigen receptor t-cell therapy process for multiple myeloma. Seminars in Oncology Nursing, https://doi.org/10.1016/j.soncn.2023.151505
Stenson, C.L., Vidrine, J., Dewhurst, F., Osborne, W., Menne, T. & Stocker, R. (2023). A qualitative service evaluation of patient and caregiver experiences of CAR-T therapy: recommendations for service development and implications for palliative care teams. Palliative Medicine, 37(2), 215-220. https://doi.org/10.1177/02692163221138880
Tan, I., Cusatis, R., Crawford, E., Thiengmany, A., Piehowski, C., Akinola, I., Cragin, J., Lahijani, S., Frank, M.J., Shah, N. N., D’Souza, A., Miklos, D., Muffly, L., Flynn, K. & Sidana, S. (2021). Do PROs tell the whole story? Differential outcomes based on patient reported outcomes (PROs) versus performance-based metrics (PBM) on cognition for patients receiving chimeric antigen receptor (CAR)-T cell therapy, Blood, 138(1), 3043-3045. https://doi.org/10.1182/blood-2021-145746
Taylor, L., Rodriguez, E.S., Reese, A. & Anderson, K. (2019). Building a program; implications for infrastructure, nursing education, and training for CAR T-cell therapy. Clinical Journal of Oncology Nursing, 23(2), 20-26. https://doi.org/10.1188/19.CJON.S1.20-26
Tuch, G., Soo, W.K., Luo, K.Y., Frearson, K., Oh, E.L., Phillips, J.L., Agar, M. & Lane, H. (2021). Cognitive assessment tools recommended in geriatric oncology guidelines: A rapid review. Current Oncology, 28(5), 3987-4003. https://doi.org/10.3390/curroncol28050339
Wang.X.S., Srour, S., Whisenant, M., Subbiah, I., Chen, T., Ponce, D., Gonzalez, G., Kamal, M., Menoza, T., Cleland, C., Kebriaei, P., Neelapu, S., Rezvani, K., Ahmed, S. & Shpall, E. (2021). Patient-reported symptom and functioning status during the first 12 months of chimeric antigen receptor T cell therapy for hematologic malignancies. Transplantation and Cellular Therapy, 27(930), e1-e10. https://doi.org/10.1016/j.jtct.2021.07.007
Williams, A., M., Zent, C.S. & Janelsins, M. (2016). What is known and unknown about chemotherapy-related cognitive impairment in patients with haematological malignancies and areas of needed research. British Journal of Hematology, 174(6), 835-846. https://doi.org/10.1111/bjh.14211
Whisenant, M.S., Srour, S.A., Williams, L.A., Subbiah, I., Griffin, D., Ponce, D., Kebriaei, P., Neelapu, S.S., Spall, E., Ahmed, S. & Wang, X.S. (2021). The unique symptom burden of patients receiving CAR-T cell therapy. Seminars in Oncology Nursing, 37(6), 151216. https://doi.org/10.1016/j.soncn.2021.151216
Valsangkar, N., Fernandez & Kullar, O. (2020). Patient reported outcomes: integration into clinical practices. Journal of Thoracic Disease, 12(11), 6940-6946. https:/doi.org/10.21037/jtd.2020.03.91
Refbacks
- There are currently no refbacks.
